C3 and Alzheimer disease: In addition to type-II interferon signaling, type-I interferon pathways are upregulated in AD patients and are significantly correlated with disease severity, and in mouse AD models, type-I signaling modulates microglial activation and complements C3-dependent synapse elimination [71].